# Sofosbuvir + Velpatasvir

## Epclusa 400/100mg

##### 臨採

| 藥品代碼   | OEPC                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|:-----------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症     | treatment of adult chronic hepatitis C virus (HCV) genotype 1， 2， 3， 4， 5 or 6 infections                                                                                                                                                                                                                                                                                                                                                                           |
| 用法用量   | One tablet contains sofosbuvir 400 mg/velpatasvir 100 mg. One tablet once daily for 12 weeks.                                                                                                                                                                                                                                                                                                                                                                           |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 腎功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 禁忌       | Hypersensitivity to sofosbuvir， velpatasvir， or any component of the formulation. If sofosbuvir/velpatasvir is administered with ribavirin， the contraindications to ribavirin also apply. See ribavirin manufacturer's labeling information.                                                                                                                                                                                                                        |
| 副作用     | >10%: Central nervous system: Headache (22%)， fatigue (15%) 1% to 10%: Central nervous system: Irritability (?5%)， insomnia (5%)， depression (1%) Dermatologic: Skin rash (2%) Gastrointestinal: Nausea (9%)， increased serum lipase (>3X ULN: 3% to 6%) Neuromuscular & skeletal: Weakness (5%)， increased creatine phosphokinase (?10X ULN: 1% to 2%) Frequency not defined: Infection: Reactivation of HBV <1%: postmarketing， and/or case reports: Angioedema |
| 孕期建議   | No Data                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 哺乳期建議 | Unknown 沒有資料                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

